LFCR LIFECORE BIOMEDICAL, INC. \DE\

Nasdaq www.landec.com


$ 6.54 $ -0.07 (-1.06 %)    

Tuesday, 14-Oct-2025 15:59:53 EDT
QQQ $ 598.50 $ -4.01 (-0.67 %)
DIA $ 463.08 $ 2.03 (0.44 %)
SPY $ 662.74 $ -0.81 (-0.12 %)
TLT $ 90.69 $ 0.29 (0.32 %)
GLD $ 382.95 $ 2.70 (0.71 %)
$ 6.54
$ 6.46
$ 6.20 x 250
$ 7.60 x 100
$ 6.33 - $ 6.67
$ 4.51 - $ 8.85
205,481
na
244.65M
$ 0.88
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 05-25-2025 10-K
2 04-03-2025 02-23-2025 10-Q
3 01-02-2025 11-24-2024 10-Q
4 10-04-2024 08-25-2024 10-Q
5 08-26-2024 05-26-2024 10-K
6 08-09-2024 08-27-2023 10-Q
7 08-09-2024 11-26-2023 10-Q
8 08-09-2024 02-25-2024 10-Q
9 03-20-2024 05-28-2023 10-K
10 06-02-2023 02-26-2023 10-Q
11 03-16-2023 11-27-2022 10-Q
12 10-07-2022 08-28-2022 10-Q
13 09-14-2022 05-29-2022 10-K
14 04-07-2022 02-27-2022 10-Q
15 01-07-2022 11-28-2021 10-Q
16 10-05-2021 08-29-2021 10-Q
17 07-29-2021 05-30-2021 10-K
18 04-08-2021 02-28-2021 10-Q
19 01-07-2021 11-29-2020 10-Q
20 10-07-2020 08-30-2020 10-Q
21 08-14-2020 05-31-2020 10-K
22 04-03-2020 02-23-2020 10-Q
23 01-02-2020 11-24-2019 10-Q
24 10-03-2019 08-25-2019 10-Q
25 08-01-2019 05-26-2019 10-K
26 04-04-2019 02-24-2019 10-Q
27 01-07-2019 11-25-2018 10-Q
28 10-05-2018 08-26-2018 10-Q
29 08-09-2018 05-27-2018 10-K
30 04-05-2018 02-25-2018 10-Q
31 01-05-2018 11-26-2017 10-Q
32 09-28-2017 08-27-2017 10-Q
33 08-11-2017 05-28-2017 10-K
34 04-07-2017 02-26-2017 10-Q
35 01-05-2017 11-27-2016 10-Q
36 09-29-2016 08-28-2016 10-Q
37 08-01-2016 05-29-2016 10-K
38 03-30-2016 02-28-2016 10-Q
39 01-07-2016 11-29-2015 10-Q
40 10-01-2015 08-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 keybanc-initiates-coverage-on-lifecore-biomedical-with-sector-weight-rating

Keybanc analyst Paul Knight initiates coverage on Lifecore Biomedical (NASDAQ:LFCR) with a Sector Weight rating.

 lifecore-biomedical-sees-fy2026-sales-74000m-76000m-vs-127802m-est

Lifecore Biomedical (NASDAQ:LFCR) sees FY2026 sales of $74.000 million-$76.000 million vs $127.802 million analyst estimate.

 lifecore-biomedical-q4-eps-006-beats-010-estimate-sales-36444m-beat-35363m-estimate

Lifecore Biomedical (NASDAQ:LFCR) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $...

 lifecore-signs-10-year-deal-to-make-eye-drug-boosting-long-term-revenue-growth-prospects

Lifecore Biomedical, Inc. (NASDAQ:LFCR) ("Lifecore"), a fully integrated contract development and manufacturing organiz...

 william-blair-initiates-coverage-on-lifecore-biomedical-with-outperform-rating

William Blair analyst Max Smock initiates coverage on Lifecore Biomedical (NASDAQ:LFCR) with a Outperform rating.

 lifecore-biomedical-q3-2025-gaap-eps-047-misses-015-estimate-sales-35154m-beat-33229m-estimate

Lifecore Biomedical (NASDAQ:LFCR) reported quarterly losses of $(0.47) per share which missed the analyst consensus estimate of...

 lifecore-biomedical-announces-17m-sales-agreement-for-10-head-isolator-filler-receives-7m-at-closing-expects-remaining-payments-in-3-tranches-over-18-months

Company Believes it is Well Positioned for Mid-Term and Long-Term Growth asCurrent Capacity Continues to Support up to $300 Mil...

 stephens--co-reiterates-equal-weight-on-lifecore-biomedical-maintains-6-price-target

Stephens & Co. analyst Jacob Johnson reiterates Lifecore Biomedical (NASDAQ:LFCR) with a Equal-Weight and maintains $6 p...

 us-stocks-poised-to-open-higher-as-futures-advance-tesla-bumble-lifecore-bio-in-focus

U.S. stock futures were higher on Friday, the slipping in first trading session of 2025. All four index futures advanced in pre...

 resources-connection-sps-commerce-and-3-stocks-to-watch-heading-into-friday

US stock futures up, GeneDx appoints new COO, Lifecore beats expectations, SPS Commerce acquires Carbon6, Resources Connection ...

 lifecore-biomedical-q2-2025-gaap-eps-025-beats-029-estimate-sales-3260m-beat-2975m-estimate

Lifecore Biomedical (NASDAQ:LFCR) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION